The research service provides an analysis of the healthcare market in Asia-Pacific (APAC). It discusses the current technology and country-specific trends and provides predictions. Market participants and key opinion leaders in APAC hospitals were interviewed to obtain their views on trends and opportunities in the healthcare industry. The regional scope of this research service includes China, India, Japan, Australia, and Association of Southeast Asian Nations (ASEAN).
Over 6 million smartphones, wearables, and remote patient monitoring devices will be shipped to APAC in 2015.
Asian companies will strengthen their position and have higher market shares compared to their MNC counterparts, especially in the low-to mid-tier technology space.
Five countries in APAC will introduce price transparency measures and innovative procurement (e-catalogs) models to tackle corruption.
MNCs will prioritize developing R&D and launch strategies for the APAC market over the needs of the markets in the West. This will be primarily to fight challenges such as infectious diseases in APAC.
Cell therapy, especially stem cell therapy for adult stem cell and embryonic stem cell will be the most attractive market in South Korea and Japan.